Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2011; 17(47): 5221-5226
Published online Dec 21, 2011. doi: 10.3748/wjg.v17.i47.5221
Published online Dec 21, 2011. doi: 10.3748/wjg.v17.i47.5221
Table 2 Patient characteristics at baseline, case (%)
Characteristics | Older group | Control group |
(n = 32) | (n = 38) | |
Demography | ||
Male/female | 24 (75)/8 (25) | 29 (76.3)/9 (23.7) |
Median age, yr (range) | 79.5 (75-89) | 64 (55-74) |
Karnofsky performance status | ||
Median | 80% | 80% |
100% | 1 (3.1) | 2 (5.3) |
90% | 10 (31.2) | 13 (34.2) |
80% | 17 (53.2) | 18 (47.4) |
60%-70% | 4 (12.5) | 5 (13.1) |
Weight loss > 5% | 11 (34.4) | 13 (34.2) |
Cardia stenosis status | ||
I-II | 0 | 0 |
III | 25 (78.1) | 29 (76.3) |
IV | 6 (18.8) | 8 (21.1) |
V | 1 (3.1) | 1 (2.6) |
Histological grade | ||
G1-2 | 17 (53.1) | 19 (50) |
G3 | 12 (37.5) | 14 (36.8) |
Others (grade not stated) | 3 (9.4) | 5 (13.2) |
Extent of disease | ||
Metastatic | 10 (31.3) | 12 (31.6) |
Locally advanced | 22 (68.7) | 26 (68.4) |
Metastatic site | ||
Lymph nodes | 10 (31.3) | 12 (31.6) |
Liver | 3 (9.4) | 3 (7.9) |
Peritoneum | 1 (3.1) | 2 (5.3) |
Lung | 0 | 1 (2.6) |
Others | 0 | 0 |
No. of metastatic sites | ||
1 | 6 (18.8) | 6 (15.8) |
≥ 2 | 4 (12.5) | 6 (15.8) |
- Citation: Gao SG, Jia RN, Feng XS, Xie XH, Shan TY, Pan LX, Song NS, Wang YF, Ding KL, Wang LD. Therapeutic effects of combined oxaliplatin and S-1 in older patients with advanced gastric cardiac adenocarcinoma. World J Gastroenterol 2011; 17(47): 5221-5226
- URL: https://www.wjgnet.com/1007-9327/full/v17/i47/5221.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i47.5221